Zolin A, Ooi H, Zhou M, Su C, Wang F, Sarva H.  2025.  Liver fibrosis associated with more severe motor deficits in early Parkinson's disease.. Clin Neurol Neurosurg. 252:108861.

Williams SC, Navas-Acien A, Goessler W, Verney SP, Erdei E, Buchwald D, Suchy-Dicey A, Best LG.  2025.  Urinary selenium, cranial MRI, and cognitive function in American Indians: The Strong Heart Study.. Environ Res. 269:120913.

Ramaswamy A, Hung M, Pelt J, Iranmahboub P, Calderon LP, Scherr IS, Wang G, Green D, Patel N, McClure TD et al..  2024.  Ascertaining provider-level implicit bias in electronic health records with rules-based natural language processing: A pilot study in the case of prostate cancer.. PLoS One. 19(12):e0314989.

Imomnazarov K, Lopez-Scarim J, Bagheri I, Joers V, Tansey MGámez, Martín-Peña A.  2024.  Biochemical Fractionation of Human α-Synuclein in a Drosophila Model of Synucleinopathies.. Int J Mol Sci. 25(7)

McIntyre CA, Grimont A, Park J, Meng Y, Sisso WJ, Seier K, Jang GHo, Walch H, Aveson VG, Falvo DJ et al..  2024.  Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer.. Cancer Cell. 42(9):1614-1629.e5.

Preston WA, Drill E, Boerner T, Gelfer R, Harding JJ, O'Reilly EM, Cercek A, Abou-Alfa G, Park W, Balachandran VP et al..  2024.  Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome.. JCO Precis Oncol. 8:e2400206.

Gelfer R, Gulla A, Kalvin HL, Song Y, Harding J, Abou-Alfa GK, O'Reilly EM, Park W, Chandwani R, Wei A et al..  2024.  KRAS Variants Are Associated With Survival Outcomes and Genomic Alterations in Biliary Tract Cancers.. JCO Precis Oncol. 8:e2400263.

Reichman M, Chen X, Lee A, Losner J, Thomas C, Katzen J.  2024.  Yield of MR-directed US for MRI-detected breast findings: how often can we avoid MR biopsy? Clin Imaging. 111:110174.

Garcia-Bermudez J, Baudrier L, Bayraktar ECan, Shen Y, La K, Guarecuco R, Yucel B, Fiore D, Tavora B, Freinkman E et al..  2019.  Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death.. Nature. 567(7746):118-122.

Pittman S, Sethi P, Flavell RR, Pampaloni MHernandez.  2018.  Cardiac Fibroma: An Uncommon Cause of a Fixed Defect on Myocardial Perfusion Imaging.. Clin Nucl Med. 43(2):e56-e58.

Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, Green JB, Buse JB, Inzucchi SE, Leiter LA et al..  2018.  Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Editors' Expert Forum. Diabetes Care. 41(1):14-31.

Mateos M-V, Dimopoulos MA, Cavo M, Suzuki K, Jakubowiak A, Knop S, Doyen C, Lucio P, Nagy Z, Kaplan P et al..  2018.  Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma.. N Engl J Med. 378(6):518-528.

Hayashi Y, Aida Y, Sasagawa Y, Oishi M, Kita D, Tachibana O, Ueda F, Nakada M.  2018.  Delayed Occurrence of Diabetes Insipidus After Transsphenoidal Surgery with Radiologic Evaluation of the Pituitary Stalk on Magnetic Resonance Imaging.. World Neurosurg. 110:e1072-e1077.

Ng QKT, Sethi P, Saunders TA, Pampaloni MHernandez, Flavell RR.  2018.  Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.. Clin Nucl Med. 43(3):e89-e92.

Campbell BCV, van Zwam WH, Goyal M, Menon BK, Dippel DWJ, Demchuk AM, Bracard S, White P, Dávalos A, Majoie CBLM et al..  2018.  Effect of general anaesthesia on functional outcome in patients with anterior circulation ischaemic stroke having endovascular thrombectomy versus standard care: a meta-analysis of individual patient data.. Lancet Neurol. 17(1):47-53.

Lee S, Kim S-J.  2018.  Efficacy and safety of ChondroT on knee-osteoarthritis: Protocol for a 8-week, randomized, double-blind, placebo-controlled, multicenter therapeutic exploratory clinical trial.. Medicine (Baltimore). 97(12):e0170.

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, Nathenson M, Doebele RC, Farago AF, Pappo AS et al..  2018.  Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.. N Engl J Med. 378(8):731-739.

Goncalves MD, Taylor S, Halpenny DF, Schwitzer E, Gandelman S, Jackson J, Lukose A, Plodkowski AJ, Tan KS, Dunphy M et al..  2018.  Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.. Clin Radiol. 73(5):505.e1-505.e8.

Castellanos JG, Woo V, Viladomiu M, Putzel G, Lima S, Diehl GE, Marderstein AR, Gandara J, Perez AR, Withers DR et al..  2018.  Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.. Immunity. 49(6):1077-1089.e5.

Lockney NA, Wang DG, Pei X, Goldman DA, Zhang Z, Lin A, Chan TA, Yamada Y, Beal K, T Yang J.  2018.  Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation.. Int J Radiat Oncol Biol Phys. 101(4):833-844.

Feng M, Marjon KD, Zhu F, Weissman-Tsukamoto R, Levett A, Sullivan K, Kao KS, Markovic M, Bump PA, Jackson HM et al..  2018.  Programmed cell removal by calreticulin in tissue homeostasis and cancer.. Nat Commun. 9(1):3194.

Patel T, Bander ED, Venn RA, Powell T, Cederquist GYoung-Min, Schaefer PM, Puchi LA, Akhmerov A, Ogilvie S, Reiner AS et al..  2018.  The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas.. Neurosurgery. 82(6):808-814.

Xue Y, Martelotto L, Baslan T, Vides A, Solomon M, Mai TThi, Chaudhary N, Riely GJ, Li BT, Scott K et al..  2017.  An approach to suppress the evolution of resistance in BRAF-mutant cancer.. Nat Med. 23(8):929-937.

Brown A, Sewell K, Fisher CA.  2017.  Characterisation of aggression in Huntington's disease: rates, types and antecedents in an inpatient rehabilitation setting.. J Clin Nurs. 26(19-20):2922-2931.

Lockney NA, Wang DG, Gutin PH, Brennan C, Tabar V, Ballangrud A, Pei X, Chan TA, Yamada Y, T Yang J et al..  2017.  Clinical outcomes of patients with limited brain metastases treated with hypofractionated (5×6Gy) conformal radiotherapy.. Radiother Oncol. 123(2):203-208.